WO2019025803A3 - Composition antimicrobienne - Google Patents

Composition antimicrobienne

Info

Publication number
WO2019025803A3
WO2019025803A3 PCT/GB2018/052208 GB2018052208W WO2019025803A3 WO 2019025803 A3 WO2019025803 A3 WO 2019025803A3 GB 2018052208 W GB2018052208 W GB 2018052208W WO 2019025803 A3 WO2019025803 A3 WO 2019025803A3
Authority
WO
WIPO (PCT)
Prior art keywords
antimicrobial composition
ajoene
honey
skin
treating
Prior art date
Application number
PCT/GB2018/052208
Other languages
English (en)
Other versions
WO2019025803A2 (fr
Inventor
Carl Jorg Michael GRAZ
Gareth James Street Evans
Danielle Michaela WILLIAMS
Original Assignee
Neem Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neem Biotech Ltd filed Critical Neem Biotech Ltd
Publication of WO2019025803A2 publication Critical patent/WO2019025803A2/fr
Publication of WO2019025803A3 publication Critical patent/WO2019025803A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une composition antimicrobienne comprenant du miel et de l'ajoène destinée à être utilisée dans le traitement ou la prévention d'une infection cutanée et/ou d'une plaie chez un sujet. L'invention concerne également des procédés de traitement ou de prévention d'une infection cutanée et/ou d'une plaie, consistant à administrer une quantité thérapeutiquement ou prophylactiquement efficace d'une composition antimicrobienne comprenant du miel et de l'ajoène à un sujet en ayant besoin.
PCT/GB2018/052208 2017-08-03 2018-08-02 Composition antimicrobienne WO2019025803A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1712501.4 2017-08-03
GBGB1712501.4A GB201712501D0 (en) 2017-08-03 2017-08-03 An antimicrobial composition

Publications (2)

Publication Number Publication Date
WO2019025803A2 WO2019025803A2 (fr) 2019-02-07
WO2019025803A3 true WO2019025803A3 (fr) 2019-05-02

Family

ID=59894943

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2018/052208 WO2019025803A2 (fr) 2017-08-03 2018-08-02 Composition antimicrobienne

Country Status (2)

Country Link
GB (1) GB201712501D0 (fr)
WO (1) WO2019025803A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113143911A (zh) * 2021-04-26 2021-07-23 吉林大学 原花青素在制备单增李斯特菌分选酶抑制剂中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925856A1 (fr) * 2007-12-28 2009-07-03 Patrick Mamou Mode operatoire specifique pour energiser l'association de differents ingredients naturels et optimiser leurs proprietes afin de leur conferer une plus grande efficacite contre des poussees d'herpes
WO2015074159A1 (fr) * 2013-11-25 2015-05-28 Dermal Devices Inc. Composition, système, et méthode pour le traitement de la peau
US20150150930A1 (en) * 2013-12-02 2015-06-04 Laïd BOUKRAA Aro-honey starch gel for wounds, burns and skin care
WO2016102931A1 (fr) * 2014-12-23 2016-06-30 Neem Biotech Ltd Composition antimicrobienne

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925856A1 (fr) * 2007-12-28 2009-07-03 Patrick Mamou Mode operatoire specifique pour energiser l'association de differents ingredients naturels et optimiser leurs proprietes afin de leur conferer une plus grande efficacite contre des poussees d'herpes
WO2015074159A1 (fr) * 2013-11-25 2015-05-28 Dermal Devices Inc. Composition, système, et méthode pour le traitement de la peau
US20150150930A1 (en) * 2013-12-02 2015-06-04 Laïd BOUKRAA Aro-honey starch gel for wounds, burns and skin care
WO2016102931A1 (fr) * 2014-12-23 2016-06-30 Neem Biotech Ltd Composition antimicrobienne

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANNABELLE WHATMOUGH ET AL: "P17 Identification of a novel synergistic combination of natural extracts for infection control in diabetic ulcers", BIOCHEMICAL PHARMACOLOGY, vol. 139, 1 September 2017 (2017-09-01), US, pages 130, XP055567285, ISSN: 0006-2952, DOI: 10.1016/j.bcp.2017.06.018 *
HARTMAN-ADAMS H ET AL: "Impetigo: Diagnosis and treatment", AMERICAN FAMILY PHYSICIAN 20140815, vol. 90, no. 4, 15 August 2014 (2014-08-15), pages 229 - 235, XP055567630, ISSN: 0002-838X *
NADALO D ET AL: "What is the best way to treat tinea cruris?", JOURNAL OF FAMILY PRAC, NEW YORK, NY, US, vol. 55, no. 3, 1 January 2006 (2006-01-01), pages 256 - 258, XP009116119, ISSN: 0094-3509 *
WESSAM A. SARHAN ET AL: "Honey/Chitosan Nanofiber Wound Dressing Enriched with Allium sativum and Cleome droserifolia : Enhanced Antimicrobial and Wound Healing Activity", ACS APPLIED MATERIALS & INTERFACES, vol. 8, no. 10, 16 March 2016 (2016-03-16), US, pages 6379 - 6390, XP055335814, ISSN: 1944-8244, DOI: 10.1021/acsami.6b00739 *

Also Published As

Publication number Publication date
WO2019025803A2 (fr) 2019-02-07
GB201712501D0 (en) 2017-09-20

Similar Documents

Publication Publication Date Title
PH12017502297A1 (en) Antibacterial compounds
NZ713621A (en) Compounds and methods of treating infections
EP3862009A4 (fr) Composition pour la régénération de la peau et la cicatrisation des plaies, comprenant des exosomes induits
BR112016030541A2 (pt) métodos para o tratamento de infecções fúngicas
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
WO2016142445A3 (fr) Méthode de traitement d'une infection bactérienne
MX2022003037A (es) Compuestos antibacterianos.
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
TW201613578A (en) Pharmaceutical combinations
MX2019001633A (es) Proteina derivada de la seda para el tratamiento de la inflamacion.
WO2017075188A3 (fr) Méthodes d'utilisation d'anticorps anti toxine alpha
WO2019157495A3 (fr) Procédés de prévention et/ou de traitement de conditions de perte osseuse par modulation de l'irisine
WO2015066302A3 (fr) Compositions, méthodes d'utilisation et méthodes de traitement
WO2014152437A3 (fr) Procédés d'utilisation d'un peptide antimicrobien
BR112019004791A2 (pt) tratamento de esclerose múltipla com chs-131
WO2015126930A3 (fr) Pharmacothérapie à effet "booster" pour lutter contre les infections à mycobacterium
EP3821884A4 (fr) Utilisation d'un composé dans un médicament servant à prévenir, à traiter ou à soulager la douleur
MX2020005056A (es) Emulsiones para el tratamiento tópico de infecciones dérmicas y de mucosas.
PH12018501624A1 (en) A composition comprising pic for treatment of cancer
WO2019025803A3 (fr) Composition antimicrobienne
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
EP3789019A4 (fr) Composition pour la prévention ou le traitement d'une infection cutanée
EA201692493A1 (ru) Противомикробные фармацевтические композиции со способностями ингибирования множественной лекарственной устойчивости
EP3744347A4 (fr) Composition pour une utilisation dans le traitement de maladies cutanées
EP3668526A4 (fr) Compositions de traitement d'infections de membranes de la peau et des muqueuses

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18833489

Country of ref document: EP

Kind code of ref document: A2